Developmental neurotoxicity of engineered nanomaterials: Identifying research needs to support human health risk assessment

Toxicological Sciences

Volumn 134, Issue 2, 2013, Pages 225-242

  Powers, Christina M ^a   Bale, Ambuja S ^b   Kraft, Andrew D ^b   Makris, Susan L ^b   Trecki, Jordan ^b   Cowden, John ^a   Hotchkiss, Andrew ^a   Gillespie, Patricia A ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Developmental neurotoxicity; Engineered nanomaterials; Risk assessment research

Indexed keywords

COPPER; IRON; MAGNETITE; MANGANESE; NANOMATERIAL; POLYSTYRENE; POVIDONE; SILVER;

ARTICLE; BEHAVIOR CHANGE; BLOOD BRAIN BARRIER; BLOOD PLACENTA BARRIER; BRAIN WEIGHT; DEVELOPMENTAL TOXICITY; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION; GROWTH; HEALTH HAZARD; HEARING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LEARNING; MEMORY; MOTOR PERFORMANCE; NANOENGINEERING; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; PLANNING; PRACTICE GUIDELINE; PRENATAL EXPOSURE; PUERPERIUM; RISK ASSESSMENT; STARTLE REFLEX; SURVIVAL; TOXICITY TESTING;

DEVELOPMENTAL NEUROTOXICITY; ENGINEERED NANOMATERIALS; RISK ASSESSMENT RESEARCH.;

ANIMALS; HUMANS; NANOSTRUCTURES; NERVOUS SYSTEM; RISK ASSESSMENT;

EID: 84880693748     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kft109     Document Type: Article

References (108)

1. Abdel-Rahman, A., Dechkovskaia, A. M., Sutton, J. M., Chen, W. C., Guan, X., Khan, W. A., and Abou-Donia, M. B. (2005). Maternal exposure of rats to nicotine via infusion during gestation produces neurobehavioral deficits and elevated expression of glial fibrillary acidic protein in the cerebellum and CA1 subfield in the offspring at puberty. Toxicology 209, 245-261.
2. Aschberger, K., Micheletti, C., Sokull-Klüttgen, B., and Christensen, F. M. (2011). Analysis of currently available data for characterising the risk of engineered nanomaterials to the environment and human health-lessons learned from four case studies. Environ. Int. 37, 1143-1156.
3. Benn, T. M., and Westerhoff, P. (2008). Nanoparticle silver released into water from commercially available sock fabrics. Environ. Sci. Technol. 42, 4133-4139.
4. Besson, S., Latzin, P., Stern, G., Strippoli, M. P. F., Kuehni, C. E., Roosli, M., and Frey, U. (2010). Influence of atmospheric parameters and pollutants on control of breathing in healthy neonates. Ann. Respir. Med. 1.
5. Blomgren, K., and Hagberg, H. (2006). Free radicals, mitochondria, and hypoxia-ischemia in the developing brain. Free Radic. Biol. Med. 40, 388-397.
6. Bondy, S. C., and Campbell, A. (2005). Developmental neurotoxicology. J. Neurosci. Res. 81, 605-612.
7. Bouwmeester, H., Lynch, I., Marvin, H. J., Dawson, K. A., Berges, M., Braguer, D., Byrne, H. J., Casey, A., Chambers, G., Clift, M. J., et al. (2011). Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices. Nanotoxicology 5, 1-11.
8. Boyes, W. K., Chen, R., Chen, C., and Yokel, R. A. (2012). The neurotoxic potential of engineered nanomaterials. Neurotoxicology 33, 902-910.
9. Burton, N. C., and Guilarte, T. R. (2009). Manganese neurotoxicity: Lessons learned from longitudinal studies in nonhuman primates. Environ. Health Perspect. 117, 325-332.
10. Buzea, C., Pacheco, I. I., and Robbie, K. (2007). Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases 2, MR17-MR71.
11. Chen, L., Yokel, R. A., Hennig, B., and Toborek, M. (2008). Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature. J. Neuroimmune Pharmacol. 3, 286-295.
12. Chithrani, B. D., Ghazani, A. A., and Chan, W. C. (2006). Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6, 662-668.
13. Cho, M., Cho, W. S., Choi, M., Kim, S. J., Han, B. S., Kim, S. H., Kim, H. O., Sheen, Y. Y., and Jeong, J. (2009). The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol. Lett. 189, 177-183.
14. Choi, J. Y., Ramachandran, G., and Kandlikar, M. (2009). The impact of toxicity testing costs on nanomaterial regulation. Environ. Sci. Technol. 43, 3030-3034.
15. Costa, L. G., Aschner, M., Vitalone, A., Syversen, T., and Soldin, O. P. (2004a). Developmental neuropathology of environmental agents. Annu. Rev. Pharmacol. Toxicol. 44, 87-110.
16. Costa, L. G., Yagle, K., Vitalone, A., and Guizzetti, M. (2004b). Alcohol and Glia in the Developing Brain. CRC Press, Boca Riton, FL.
17. Dahm, M. M., Yencken, M. S., and Schubauer-Berigan, M. K. (2011). Exposure control strategies in the carbonaceous nanomaterial industry. J. Occup. Environ. Med. 53(6 Suppl), S68-S73.
18. de Esch, C., Slieker, R., Wolterbeek, A., Woutersen, R., and de Groot, D. (2012). Zebrafish as potential model for developmental neurotoxicity testing: A mini review. Neurotoxicol. Teratol. 34, 545-553.
19. De Jong, W. H., Hagens, W. I., Krystek, P., Burger, M. C., Sips, A. J., and Geertsma, R. E. (2008). Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29, 1912-1919.
20. Elder, A., Gelein, R., Silva, V., Feikert, T., Opanashuk, L., Carter, J., Potter, R., Maynard, A., Ito, Y., Finkelstein, J., et al. (2006). Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ. Health Perspect. 114, 1172-1178.
21. Fadri, G., Sonderer, T., Scholz, R. W., and Nowack, B. (2009). Modeled environmental concentrations of engineered nanomaterials (TiO2, ZnO, Ag, CNT, fullerenes) for different regions. Environ. Sci. Technol. 43, 9216-9222.
22. Gangwal, S., Brown, J. S., Wang, A., Houck, K. A., Dix, D. J., Kavlock, R. J., and Hubal, E. A. (2011). Informing selection of nanomaterial concentrations for ToxCast in vitro testing based on occupational exposure potential. Environ. Health Perspect. 119, 1539-1546.
23. Gao, X., Yin, S., Tang, M., Chen, J., Yang, Z., Zhang, W., Chen, L., Yang, B., Li, Z., Zha, Y., et al. (2011). Effects of developmental exposure to TiO2 nanoparticles on synaptic plasticity in hippocampal dentate gyrus area: An in vivo study in anesthetized rats. Biol. Trace Elem. Res. 143, 1616-1628.
24. Golan, H. M., Lev, V., Hallak, M., Sorokin, Y., and Huleihel, M. (2005). Specific neurodevelopmental damage in mice offspring following maternal inflammation during pregnancy. Neuropharmacology 48, 903-917.
25. Gottschalk F., Sonderer, T., Scholz, R. W., and Nowack, B. (2009). Modeled Environmental Concentrations of Engineered Nanomaterials (TiO2, ZnO, Ag, CNT, Fullerenes) for Different Regions. Environ Sci Technol. 43, 9216-9222.
26. Grandjean, P., and Landrigan, P. J. (2006). Developmental neurotoxicity of industrial chemicals. Lancet 368, 2167-2178.
27. Grieneisen, M. L., and Zhang, M. (2011). Nanoscience and nanotechnology: Evolving definitions and growing footprint on the scientific landscape. Small 7, 2836-2839.
28. Guizzetti, M., Catlin, M., and Costa, L. G. (1997). The effects of ethanol on glial cell proliferation: Relevance to the fetal alcohol syndrome. Front. Biosci. 2, e93-e98.
29. Gulson, B., McCall, M., Korsch, M., Gomez, L., Casey, P., Oytam, Y., Taylor, A., McCulloch, M., Trotter, J., Kinsley, L., et al. (2010). Small amounts of zinc from zinc oxide particles in sunscreens applied outdoors are absorbed through human skin. Toxicol. Sci. 118, 140-149.
30. Hagberg, H., and Mallard, C. (2005). Effect of inflammation on central nervous system development and vulnerability. Curr. Opin. Neurol. 18, 117-123.
31. Hansen, S. F., Michelson, E. S., Kamper, A., Borling, P., Stuer-Lauridsen, F., and Baun, A. (2008). Categorization framework to aid exposure assessment of nanomaterials in consumer products. Ecotoxicology 17, 438-447.
32. Hardas, S. S., Butterfield, D. A., Sultana, R., Tseng, M. T., Dan, M., Florence, R. L., Unrine, J. M., Graham, U. M., Wu, P., Grulke, E. A., et al. (2010). Brain distribution and toxicological evaluation of a systemically delivered engineered nanoscale ceria. Toxicol. Sci. 116, 562-576.
33. Hendren, C. O., Mesnard, X., Dröge, J., and Wiesner, M. R. (2011). Estimating production data for five engineered nanomaterials as a basis for exposure assessment. Environ. Sci. Technol. 45, 2562-2569.
34. Hougaard, K. S., Jackson, P., Jensen, K. A., Sloth, J. J., Löschner, K., Larsen, E. H., Birkedal, R. K., Vibenholt, A., Boisen, A. M., Wallin, H., et al. (2010). Effects of prenatal exposure to surface-coated nanosized titanium dioxide (UV-Titan). A study in mice. Part. Fibre Toxicol. 7, 16.
35. Hu, Y. L., and Gao, J. Q. (2010). Potential neurotoxicity of nanoparticles. Int. J. Pharm. 394, 115-121.
36. Hutter, E., Boridy, S., Labrecque, S., Lalancette-Hébert, M., Kriz, J., Winnik, F. M., and Maysinger, D. (2010). Microglial response to gold nanoparticles. ACS Nano 4, 2595-2606.
37. Innovative Research and Products Incorporated (2011). Production and applications of carbon nanotubes, carbon nanofibers, fullerenes, graphene and nanodiamonds: A global technology survey and market analysis. Technical report et-113, 531.
38. Jackson, P., Vogel, U., Wallin, H., and Hougaard, K. S. (2011). Prenatal exposure to carbon black (printex 90): Effects on sexual development and neurofunction. Basic Clin. Pharmacol. Toxicol. 109, 434-437.
39. Johnston, H. J., Hutchison, G., Christensen, F. M., Peters, S., Hankin, S., and Stone, V. (2010). A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity. Crit. Rev. Toxicol. 40, 328-346.
40. Kreuter, J. (2004). Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain. J. Nanosci. Nanotechnol. 4, 484-488.
41. Kumar, K. K., Aboud, A. A., and Bowman, A. B. (2012). The potential of induced pluripotent stem cells as a translational model for neurotoxicological risk. Neurotoxicology 33, 518-529.
42. Lansdown, A. B. (2007). Critical observations on the neurotoxicity of silver. Crit. Rev. Toxicol. 37, 237-250.
43. Lehman, J. H., Terrones, M., Mansfield, E., Hurst, K. E., and Meunier, V. (2011). Evaluating the characteristics of multiwall carbon nanotubes. Carbon 49, 2581-2602.
44. Lockman, P. R., Mumper, R. J., Khan, M. A., and Allen, D. D. (2002). Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev. Ind. Pharm. 28, 1-13.
45. Luther, E. M., Koehler, Y., Diendorf, J., Epple, M., and Dringen, R. (2011). Accumulation of silver nanoparticles by cultured primary brain astrocytes. Nanotechnology 22, 375101.
46. Ma, L., Liu, J., Li, N., Wang, J., Duan, Y., Yan, J., Liu, H., Wang, H., and Hong, F. (2010). Oxidative stress in the brain of mice caused by translocated nanoparticulate TiO2 delivered to the abdominal cavity. Biomaterials 31, 99-105.
47. Makris, S. L., and Raffaele, K. C. (2009). Developmental Neurotoxicity. John Wiley & Sons, New York, NY.
48. Makris, S. L., Raffaele, K., Allen, S., Bowers, W. J., Hass, U., Alleva, E., Calamandrei, G., Sheets, L., Amcoff, P., Delrue, N., et al. (2009). A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426. Environ. Health Perspect. 117, 17-25.
49. Maynard, A. D. (2011). Don't define nanomaterials. Nature 475, 31.
50. Maynard, A. D., Warheit, D. B., and Philbert, M. A. (2011). The new toxicology of sophisticated materials: Nanotoxicology and beyond. Toxicol. Sci. 120(Suppl. 1), S109-S129.
51. Maysinger, D., Behrendt, M., Lalancette-Hébert, M., and Kriz, J. (2007). Realtime imaging of astrocyte response to quantum dots: In vivo screening model system for biocompatibility of nanoparticles. Nano Lett. 7, 2513-2520.
52. Méndez-Armenta, M., and Ríos, C. (2007). Cadmium neurotoxicity. Environ. Toxicol. Pharmacol. 23, 350-358.
53. Monteiro-Riviere, N. A., Inman, A. O., and Zhang, L. W. (2009). Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol. Appl. Pharmacol. 234, 222-235.
54. Mühlfield, C., Rothen-Rutishause, B., Blank, F., Vanhecke, D., Ochs, M., and Gehr, P. (2008). Interactions of nanoparticles with pulmonary structures and cellular response. Am. J. Physiol. Lung Cell Mol. Physiol. 294, L817-L829.
55. Nel, A., Xia, T., Meng, H., Wang, X., Lin, S., Ji, Z., and Zhang, H. (2012). Nanomaterial toxicity testing in the 21st century: Use of a predictive toxicological approach and high-throughput screening. Acc. Chem Res. 46, 607-621.
56. NRC (1983). Risk Assessment in the Federal Government: Managing the Process. National Academies Press, Washington, DC.
57. NRC (1994). Science and Judgment in Risk Assessment. National Academy Press, Washington, DC.
58. NRC (2009). Science and Decisions: Advancing Risk Assessment. National Academies Press, Washington, DC.
59. NRC (2012). A Research Strategy for Environmental, Health, and Safety Aspects of Engineered Nanomaterials. National Academies Press, Washington, DC.
60. NSTC (2011). National Nanotechnology Initiative: Environmental, Health, and Safety Research Strategy. National Nanotechnology Initiative, Arlington, VA.
61. Oberdörster, G., Elder, A., and Rinderknecht, A. (2009). Nanoparticles and the brain: Cause for concern? J. Nanosci. Nanotechnol. 9, 4996-5007.
62. Oberdörster, G., Oberdörster, E., and Oberdörster, J. (2005). Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113, 823-839.
63. OECD (2007). OECD Guideline for the Testing of Chemicals Developmental Neurotoxicity Study. Organization for Economic Co-operation and Development, Paris, France.
64. Oszlánczi, G., Vezér, T., Sárközi, L., Horváth, E., Kónya, Z., and Papp, A. (2010). Functional neurotoxicity of Mn-containing nanoparticles in rats. Ecotoxicol. Environ. Saf. 73, 2004-2009.
65. Oszlánczi, G., Vezér, T., Sárközi, L., Horváth, E., Szabó, A., Horváth, E., Kónya, Z., and Papp, A. (2010). Metal deposition and functional neurotoxicity in rats after 3-6 weeks nasal exposure by two physicochemical forms of manganese. Environ. Toxicol. Pharmacol. 30, 121-126.
66. Phenrat, T., Long, T. C., Lowry, G. V., and Veronesi, B. (2009). Partial oxidation ("aging") and surface modification decrease the toxicity of nanosized zerovalent iron. Environ. Sci. Technol. 43, 195-200.
67. Popov, A., Zhao, X., Zvyagin, A., Lademann, J., Roberts, M., Sanchez, W., Priezzhev, A., and Myllylä, R. (2010). ZnO and TiO2 particles: A study on nanosafety and photoprotection. Proc. SPIE 7715, 77153G77151-77153G77157.
68. Powers, C. M., Badireddy, A. R., Ryde, I. T., Seidler, F. J., and Slotkin, T. A. (2011). Silver nanoparticles compromise neurodevelopment in PC12 cells: Critical contributions of silver ion, particle size, coating, and composition. Environ. Health Perspect. 119, 37-44.
69. Rice, D., and Barone, S., Jr. (2000). Critical periods of vulnerability for the developing nervous system: Evidence from humans and animal models. Environ. Health Perspect. 108(Suppl. 3), 511-533.
70. Roberts, J. E., Wielgus, A. R., Boyes, W. K., Andley, U., and Chignell, C. F. (2008). Phototoxicity and cytotoxicity of fullerol in human lens epithelial cells. Toxicol. Appl. Pharmacol. 228, 49-58.
71. Sanders, K., Degn, L. L., Mundy, W. R., Zucker, R. M., Dreher, K., Zhao, B., Roberts, J. E., and Boyes, W. K. (2012). In vitro phototoxicity and hazard identification of nano-scale titanium dioxide. Toxicol. Appl. Pharmacol. 258, 226-236.
72. Saunders, M. (2009). Transplacental transport of nanomaterials. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1, 671-684.
73. Savolainen, K., Alenius, H., Norppa, H., Pylkkänen, L., Tuomi, T., and Kasper, G. (2010). Risk assessment of engineered nanomaterials and nanotechnologies- a review. Toxicology 269, 92-104.
74. Schwartz, P. M., Jacobson, S. W., Fein, G., Jacobson, J. L., and Price, H. A. (1983). Lake Michigan fish consumption as a source of polychlorinated biphenyls in human cord serum, maternal serum, and milk. Am. J. Public Health 73, 293-296.
75. Selevan, S. G., Kimmel, C. A., and Mendola, P. (2000). Identifying critical windows of exposure for children's health. Environ. Health Perspect. 108(Suppl. 3), 451-455.
76. Shanker, G., Syversen, T., and Aschner, M. (2003). Astrocyte-mediated methylmercury neurotoxicity. Biol. Trace Elem. Res. 95, 1-10.
77. Sharma, H. S., Ali, S. F., Hussain, S. M., Schlager, J. J., and Sharma, A. (2009). Influence of engineered nanoparticles from metals on the blood-brain barrier permeability, cerebral blood flow, brain edema and neurotoxicity. An experimental study in the rat and mice using biochemical and morphological approaches. J. Nanosci. Nanotechnol. 9, 5055-5072.
78. Sharma, H. S., and Sharma, A. (2007). Nanoparticles Aggravate Heat Stress Induced Cognitive Deficits, Blood-Brain Barrier Disruption, Edema Formation and Brain Pathology, Vol. 162. Elsevier B.V., New York, NY.
79. Sharma, H. S., and Sharma, A. (2010). Conference scene: Nanoneuroprotection and nanoneurotoxicity: Recent progress and future perspectives. Nanomedicine (Lond). 5, 533-537.
80. Sherwood, L. (2013). Human Physiology from Cells to Systems, 477. Brooks/ Cole, Cengage Learning, Belmont, CA.
81. Shimizu, M., Tainaka, H., Oba, T., Mizuo, K., Umezawa, M., and Takeda, K. (2009). Maternal exposure to nanoparticulate titanium dioxide during the prenatal period alters gene expression related to brain development in the mouse. Part. Fibre Toxicol. 6, 20.
82. Simkó, M., and Mattsson, M. O. (2010). Risks from accidental exposures to engineered nanoparticles and neurological health effects: A critical review. Part. Fibre Toxicol. 7, 42.
83. Stone, V., Johnston, H., and Clift, M. J. (2007). Air pollution, ultrafine and nanoparticle toxicology: Cellular and molecular interactions. IEEE Trans. Nanobioscience 6, 331-340.
84. Takahashi, Y., Mizuo, K., Shinkai, Y., Oshio, S., and Takeda, K. (2010). Prenatal exposure to titanium dioxide nanoparticles increases dopamine levels in the prefrontal cortex and neostriatum of mice. J. Toxicol. Sci. 35, 749-756.
85. Takeda, K., Suzuki, K. I., Ishihara, A., Kubo-Irie, M., Fujimoto, R., Tabata, M., Oshio, S., Nihei, Y., Ihara, T., and Sugamata, M. (2009). Nanoparticles transferred from pregnant mice to their offspring can damage the genital and cranial nerve systems. J. Health Sci. 55, 95-102.
86. Tanaka, J., Toku, K., Zhang, B., Ishihara, K., Sakanaka, M., and Maeda, N. (1999). Astrocytes prevent neuronal death induced by reactive oxygen and nitrogen species. Glia 28, 85-96.
87. Tang, J., Xiong, L., Wang, S., Wang, J., Liu, L., Li, J., Yuan, F., and Xi, T. (2009a). Distribution, translocation and accumulation of silver nanoparticles in rats. J. Nanosci. Nanotechnol. 9, 4924-4932.
88. Tang, J., Xiong, L., Zhou, G., Wang, S., Wang, J., Liu, L., Li, J., Yuan, F., Lu, S., Wan, Z., et al. (2010). Silver nanoparticles crossing through and distribution in the blood-brain barrier in vitro. J. Nanosci. Nanotechnol. 10, 6313-6317.
89. Tang, M., Li, Z., Chen, L., Xing, T., Hu, Y., Yang, B., Ruan, D. Y., Sun, F., and Wang, M. (2009b). The effect of quantum dots on synaptic transmission and plasticity in the hippocampal dentate gyrus area of anesthetized rats. Biomaterials 30, 4948-4955.
90. Teeguarden, J. G., Hinderliter, P. M., Orr, G., Thrall, B. D., and Pounds, J. G. (2006). Particokinetics in vitro: Dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol. Sci. 95, 300-312.
91. Thomas, D. G., Gaheen, S., Harper, S. L., Fritts, M., Klaessig, F., Hahn-Dantona, E., Paik, D., Pan, S., Stafford, G. A., Freund, E. T., et al. (2013). ISA-TAB-Nano: A specification for sharing nanomaterial research data in spreadsheet-based format. BMC Biotechnol. 13, 2.
92. Trickler, W. J., Lantz, S. M., Murdock, R. C., Schrand, A. M., Robinson, B. L., Newport, G. D., Schlager, J. J., Oldenburg, S. J., Paule, M. G., Slikker, W., Jr, et al. (2010). Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells. Toxicol. Sci. 118, 160-170.
93. Trickler, W. J., Lantz, S. M., Murdock, R. C., Schrand, A. M., Robinson, B. L., Newport, G. D., Schlager, J. J., Oldenburg, S. J., Paule, M. G., Slikker, W., Jr, et al. (2011). Brain microvessel endothelial cells responses to gold nanoparticles: In vitro pro-inflammatory mediators and permeability. Nanotoxicology 5, 479-492.
94. U.S. EPA (1998). Health Effects Test Guidelines OPPTS 870.6300 Developmental Neurotoxicity Study. U.S. Environmentall Protection Agency, Washington, DC.
95. U.S. EPA (2011). Exposure Factors Handbook: 2011 Edition (Final). U.S. Environmental Protection Agency, Washington, DC, EPA/600/R-09/052F.
96. Wang, J., Chen, C., Liu, Y., Jiao, F., Li, W., Lao, F., Li, Y., Li, B., Ge, C., Zhou, G., et al. (2008a). Potential neurological lesion after nasal instillation of TiO(2) nanoparticles in the anatase and rutile crystal phases. Toxicol. Lett. 183, 72-80.
97. Wang, J., Liu, Y., Jiao, F., Lao, F., Li, W., Gu, Y., Li, Y., Ge, C., Zhou, G., Li, B., et al. (2008b). Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO(2) nanoparticles. Toxicology 254, 82-90.
98. Wang, J., Rahman, M. F., Duhart, H. M., Newport, G. D., Patterson, T. A., Murdock, R. C., Hussain, S. M., Schlager, J. J., and Ali, S. F. (2009). Expression changes of dopaminergic system-related genes in PC12 cells induced by manganese, silver, or copper nanoparticles. Neurotoxicology 30, 926-933.
99. Watson, R. E., Desesso, J. M., Hurtt, M. E., and Cappon, G. D. (2006). Postnatal growth and morphological development of the brain: A species comparison. Birth Defects Res. B. Dev. Reprod. Toxicol. 77, 471-484.
100. Wick, P., Malek, A., Manser, P., Meili, D., Maeder-Althaus, X., Diener, L., Diener, P. A., Zisch, A., Krug, H. F., and von Mandach, U. (2010). Barrier capacity of human placenta for nanosized materials. Environ. Health Perspect. 118, 432-436.
101. Wielgus, A. R., Zhao, B., Chignell, C. F., Hu, D. N., and Roberts, J. E. (2010). Phototoxicity and cytotoxicity of fullerol in human retinal pigment epithelial cells. Toxicol. Appl. Pharmacol. 242, 79-90.
102. Wijnhoven, S. W. P., Peijnenburg, W. J. G. M., Herberts, C. A., Hagens, W. I., Oomen, A. G., Heugens, E. H. W., Roszek, B., Bisschops, J., Gosens, I., van de Meent, D., et al. (2009). Nano-silver: A review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 3, 109-138.
103. Wrighton, S. A., and Stevens, J. C. (1992). The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol. 22, 1-21.
104. Xia, T., Kovochich, M., Liong, M., Zink, J. I., and Nel, A. E. (2008). Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways. ACS Nano 2, 85-96.
105. Yamashita, K., Yoshioka, Y., Higashisaka, K., Mimura, K., Morishita, Y., Nozaki, M., Yoshida, T., Ogura, T., Nabeshi, H., Nagano, K., et al. (2011). Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat. Nanotech. 6, 321-328.
106. Yang, Z., Liu, Z. W., Allaker, R. P., Reip, P., Oxford, J., Ahmad, Z., and Ren, G. (2010). A review of nanoparticle functionality and toxicity on the central nervous system. J. R. Soc. Interface 7(Suppl. 4), S411-S422.
107. Yokel, R. A., and Macphail, R. C. (2011). Engineered nanomaterials: Exposures, hazards, and risk prevention. J. Occup. Med. Toxicol. 6, 7.
108. Zhang, Y., Ferguson, S. A., Watanabe, F., Jones, Y., Xu, Y., Biris, A. S., Hussain, S., Ali, S. F. (2013). Silver nanoparticles decrease body weight and locomotor activity in adult male rats. Small. 9, 1715-1720.